KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoodRx Holdings (GDRX) Other Non-Current Liabilities (2019 - 2025)

Historic Other Non-Current Liabilities for GoodRx Holdings (GDRX) over the last 7 years, with Q3 2025 value amounting to $7.6 million.

  • GoodRx Holdings' Other Non-Current Liabilities fell 1383.16% to $7.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.6 million, marking a year-over-year decrease of 1383.16%. This contributed to the annual value of $6.8 million for FY2024, which is 1739.02% down from last year.
  • Per GoodRx Holdings' latest filing, its Other Non-Current Liabilities stood at $7.6 million for Q3 2025, which was down 1383.16% from $7.0 million recorded in Q2 2025.
  • GoodRx Holdings' 5-year Other Non-Current Liabilities high stood at $9.6 million for Q2 2023, and its period low was $4.7 million during Q1 2022.
  • For the 5-year period, GoodRx Holdings' Other Non-Current Liabilities averaged around $7.3 million, with its median value being $7.6 million (2022).
  • As far as peak fluctuations go, GoodRx Holdings' Other Non-Current Liabilities tumbled by 2508.76% in 2022, and later skyrocketed by 7004.04% in 2023.
  • Quarter analysis of 5 years shows GoodRx Holdings' Other Non-Current Liabilities stood at $5.4 million in 2021, then surged by 40.41% to $7.6 million in 2022, then rose by 8.2% to $8.2 million in 2023, then fell by 17.39% to $6.8 million in 2024, then increased by 11.96% to $7.6 million in 2025.
  • Its Other Non-Current Liabilities stands at $7.6 million for Q3 2025, versus $7.0 million for Q2 2025 and $6.9 million for Q1 2025.